Immunogenicity and Safety of BNT162b2 Homologous Booster Vaccination in People Living with HIV under Effective cART

Data on COVID-19 boosting vaccination in people living with HIV (PLWH) are scant. We investigated the immunogenicity and safety of the BNT162b2 homologous boosting vaccination. Anti-SARS-CoV-2 spike antibodies (LIAISON(®) SARS-CoV-2 S1/S2 IgG test, DiaSorin(®)), CD4+, CD8+ and viraemia were monitore...

Descripción completa

Detalles Bibliográficos
Autores principales: Gianserra, Laura, Donà, Maria Gabriella, Giuliani, Eugenia, Stingone, Christof, Pontone, Martina, Buonomini, Anna Rita, Giuliani, Massimo, Pimpinelli, Fulvia, Morrone, Aldo, Latini, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414483/
https://www.ncbi.nlm.nih.gov/pubmed/36016131
http://dx.doi.org/10.3390/vaccines10081243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414483/
https://www.ncbi.nlm.nih.gov/pubmed/36016131
http://dx.doi.org/10.3390/vaccines10081243

Ejemplares similares